Investigational Drug Information for Ceftobiprole
✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
What is the drug development status for Ceftobiprole?
Ceftobiprole is an investigational drug.
There have been 22 clinical trials for Ceftobiprole. The most recent clinical trial was a Phase 3 trial, which was initiated on September 1st 2005.
The most common disease conditions in clinical trials are Infections, Infection, and Communicable Diseases. The leading clinical trial sponsors are Basilea Pharmaceutica, Johnson & Johnson Pharmaceutical Research & Development, L.L.C., and Department of Health and Human Services.
Summary for Ceftobiprole
|US Patent Applications||2,304|
|WIPO Patent Applications||1,345|
|Japanese Patent Applications||2|
|Clinical Trial Progress||Phase 3 (2005-09-01)|
Recent Clinical Trials for Ceftobiprole
|Late-onset Sepsis in Term and Pre-term Neonates and Infants up to 3 Months of Age||Basilea Pharmaceutica||Phase 3|
|Pharmacokinetics of High-dose Ceftobiprole in Community-acquired Pneumonia Under Mechanical Ventilation.||Centre Hospitalier Lyon Sud||N/A|
|Pharmacokinetics of High-dose Ceftobiprole in Community-acquired Pneumonia Under Mechanical Ventilation.||CHU de Nîmes||N/A|
Clinical Trial Summary for Ceftobiprole
Top disease conditions for Ceftobiprole
Top clinical trial sponsors for Ceftobiprole
US Patents for Ceftobiprole
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|